background
medicin
treatment
coronaviru
infect
urgent
need
howev
drug
screen
use
live
requir
highlevel
biosafeti
facil
impos
obstacl
institut
without
facil
studi
aim
repurpos
clinic
approv
drug
treatment
coronaviru
diseas
coronaviru
model
method
pangolin
coronaviru
describ
whether
use
angiotensinconvert
enzym
cell
receptor
investig
use
small
interf
rna
sirna
mediat
silenc
pangolin
coronaviru
model
use
identifi
drug
candid
treat
infect
two
librari
clinic
approv
drug
screen
abil
inhibit
cytopath
effect
vero
cell
infect
antivir
activ
antivir
mechan
potenti
drug
investig
viral
yield
rna
infecti
particl
quantifi
quantit
realtim
polymeras
chain
reaction
qrtpcr
plaqu
assay
respect
result
spike
protein
coronaviru
share
amino
acid
ident
isol
use
receptor
infect
like
three
drug
includ
cepharanthin
cep
selamectin
mefloquin
hydrochlorid
exhibit
complet
inhibit
cytopath
effect
cell
cultur
mmoll
cep
demonstr
potent
inhibit
infect
concentr
maxim
effect
ec
mmoll
viral
rna
yield
cell
treat
mmoll
cep
lower
cell
without
cep
treatment
vs
p
h
postinfect
pi
plaqu
assay
found
product
live
virus
media
contain
mmoll
cep
h
pi
furthermor
found
cep
potent
antivir
activ
viral
entri
p
viral
replic
vs
p
conclus
pangolin
coronaviru
workabl
model
research
cep
selamectin
mefloquin
hydrochlorid
potenti
drug
treat
infect
result
strongli
suggest
cep
widespectrum
inhibitor
panbetacoronaviru
studi
cep
treatment
infect
warrant
origin
articl
p
vero
cell
transfect
nmoll
sirna
nsc
sirna
use
rnaimax
transfect
reagent
h
pt
cell
infect
pangolin
cov
moi
approxim
h
pi
covinfect
cell
lyse
lysi
buffer
rna
level
cov
bactin
determin
qrtpcr
coronaviru
diseas
covid
caus
novel
coronaviru
first
detect
wuhan
china
decemb
impos
grand
immedi
challeng
global
public
health
far
spread
mani
countri
thousand
infect
case
major
affect
area
mainland
china
death
toll
number
confirm
case
still
grow
urgent
need
effect
vaccin
specif
therapi
prevent
treatment
infect
coronaviru
close
relat
identifi
sampl
collect
rhinolophu
affini
bat
yunnan
suggest
bat
like
reservoir
recent
search
reservoir
intermedi
host
turn
pangolin
xiao
et
al
report
isol
character
coronaviru
pangolin
mani
javanica
similarli
octob
viral
metagenom
studi
pangolin
identifi
sever
acut
respiratori
syndromecoronaviru
sarscov
relat
sequenc
reidentifi
sequenc
moreov
also
report
isol
identif
coronavirus
pangolin
seiz
antismuggl
oper
southern
china
altogeth
pangolin
like
reservoir
intermedi
host
due
pathogen
transmiss
work
live
requir
highlevel
biocontain
facil
imped
urgent
need
drug
screen
without
prior
experi
therapi
current
treatment
infect
mainli
empir
symptomat
limit
number
therapeut
ongo
clinic
trial
adopt
previou
research
sarscov
middl
east
respiratori
syndromecoronaviru
merscov
remot
relat
low
pathogen
human
close
genet
relationship
pangolin
coronaviru
provid
ideal
altern
model
research
reason
isol
low
pathogen
human
base
fact
back
suspect
infect
found
close
contact
pangolin
pangolin
coronaviru
isol
routin
cultur
biosafeti
level
facil
present
screen
clinic
approv
drug
anticoronaviru
activ
coronaviru
model
identifi
potent
inhibitor
pangolin
coronaviru
infect
vero
cell
american
type
cultur
collect
manassa
va
usa
grown
highglucosecontain
dulbecco
modifi
eagl
medium
supplement
fetal
bovin
serum
coronaviru
isol
vero
cell
dead
smuggl
pangolin
complet
genom
submit
genbank
librari
approv
drug
catalog
librari
antiviru
compound
catalog
produc
targetmol
purchas
topscienc
shanghai
china
oligonucleotid
use
studi
found
supplementari
tabl
http
link
confluent
monolay
vero
cell
infect
serial
tenfold
dilut
rang
h
postinfect
pi
viru
remov
cell
wash
twice
phosphatebuff
salin
ml
agaros
overlay
ad
well
prevent
crosscontamin
day
pi
day
pi
cell
fix
paraformaldehyd
h
room
temperatur
upper
semisolid
agaros
medium
remov
fix
cell
stain
crystal
violet
min
rins
water
gentli
sever
time
number
plaqu
count
viru
titer
calcul
sirnamedi
silenc
angiotensinconvert
enzym
vero
cell
transfect
nmoll
angiotensinconvert
enzym
specif
sirnapool
neg
control
sirna
sinc
use
rnaimax
transfect
reagent
invitrogen
carlsbad
ca
usa
previous
describ
h
posttransfect
pt
cell
infect
cell
culturegrown
multipl
infect
moi
approxim
h
pi
cell
lyse
lysi
buffer
messeng
rna
mrna
level
bactin
determin
quantit
realtim
polymeras
chain
reaction
qrtpcr
drug
screen
use
approv
drug
librari
vero
cell
plate
well
plate
densiti
cellswel
cell
treat
moi
differ
chemic
drug
approv
drug
librari
final
concentr
mmoll
h
pi
drug
remov
fresh
cultur
medium
contain
mmoll
drug
ad
well
h
pi
cytopath
effect
cpe
observ
use
microscopi
nikon
cat
tokyo
japan
cell
well
without
obviou
cpe
analyz
tabl
http
pcr
product
insert
vector
ruibo
xingk
biotech
beij
china
gener
standard
plasmid
sequenc
confirm
standard
curv
gener
determin
copi
number
serial
dilut
copi
plasmid
qrtpcr
amplif
sybr
green
method
perform
follow
min
follow
cycl
consist
taqman
method
perform
follow
min
min
follow
cycl
consist
min
cepharanthin
cep
mmoll
use
time
addit
experi
vero
cell
cellswel
chines
medic
journal
vol
wwwcmjorg
plate
well
plate
treat
cep
differ
stage
viru
infect
full
time
treatment
entri
treatment
postentri
treatment
experi
perform
accord
previou
studi
cytotox
cep
vero
cell
measur
cell
titer
blue
accord
manufactur
protocol
promega
catalog
number
madison
wi
usa
data
analyz
use
graphpad
prism
softwar
graphpad
softwar
inc
san
diego
ca
usa
present
mean
standard
deviat
normal
distribut
data
check
kolmogorovsmirnov
test
comparison
two
group
analyz
use
student
test
p
valu
consid
statist
signific
report
identif
coronavirus
compos
lineag
coronavirus
found
eight
pangolin
sampl
three
bat
sampl
isol
hitherto
one
coronavirus
cultur
wildlif
spike
protein
share
amino
acid
ident
spike
protein
isol
major
differ
domain
especi
receptorbind
domain
rbd
align
receptor
bind
motif
lineag
reveal
surpris
divers
five
critic
residu
postul
bind
coronaviru
rbd
human
protein
figur
compar
five
critic
residu
sarscov
two
four
replac
differ
residu
cell
receptor
sarscov
bat
sarslik
cov
next
test
whether
involv
pangolin
cov
infect
use
sirnamedi
knockdown
express
vero
cell
treat
nmoll
concentr
sirna
yield
mrna
viral
rna
significantli
reduc
suggest
express
knock
sirna
figur
also
receptor
figur
appear
conserv
receptor
sarscov
virus
note
howev
possibl
receptor
correl
viral
pathogen
fact
human
infect
relat
pangolin
cov
identifi
suspect
suggest
cov
nonpathogen
human
altogeth
close
relationship
share
receptor
nonpathogen
support
pangolin
cov
use
access
vitro
model
develop
therapi
among
three
drug
candid
cep
particular
attent
due
profound
antivir
activ
previou
report
inhibitori
effect
sarscov
figur
next
investig
drug
antivir
mechan
conduct
viral
entri
postentri
fulltim
assay
well
plate
figur
viral
entri
assay
cell
incub
media
contain
virus
cep
first
h
infect
wash
phosphatebuff
salin
supplement
media
contain
drug
viral
postentri
assay
cell
incub
media
contain
cep
first
h
infect
supplement
media
contain
cep
viral
fulltim
assay
cell
constantli
incub
media
contain
cep
viral
rna
yield
determin
qrtpcr
h
pi
compar
normal
infect
without
drug
treatment
viral
rna
yield
entri
postentri
fulltim
assay
vs
p
vs
p
vs
p
lower
respect
plaqu
assay
found
product
live
virus
media
contain
mmoll
cep
h
pi
figur
thu
data
suggest
cep
potent
inhibit
coronaviru
infect
viral
entri
postentri
first
describ
coronaviru
model
research
model
suitabl
work
biosafeti
identifi
three
clinic
approv
drug
cep
selamectin
mefloquin
hydrochlorid
inhibit
coronaviru
infect
suggest
drug
consid
investig
treatment
infect
find
cep
potenti
drug
especi
instruct
drug
antiinflammatori
antineoplast
alkaloid
approv
leukopenia
multipl
function
inhibit
efflux
transport
antitumor
drug
inhibit
entri
human
immunodefici
viru
type
reduc
plasma
membran
fluiditi
bind
central
portion
heat
shock
protein
importantli
natur
occur
plant
alkaloid
year
clinic
use
cep
low
toxic
anim
signific
side
effect
human
given
observ
strong
inhibit
viru
replic
drug
establish
role
antiinflammatori
respons
think
cep
promis
candid
treatment
infect
nonetheless
find
cep
mefloquin
agent
agreement
previou
studi
coronavirus
genu
betacoronaviru
two
group
report
cep
drug
candid
sarscov
respect
mefloquin
approv
malaria
found
antivir
activ
merscov
sarscov
furthermor
identifi
previous
librari
drug
use
studi
contain
compound
total
mani
antivir
activ
merscov
sarscov
clearli
find
three
inhibitor
comprehens
answer
potenti
inhibitor
librari
goal
find
drug
potent
antivir
activ
initi
screen
viru
inhibit
observ
exist
intact
cell
monolay
quantit
method
conclus
first
report
model
suggest
three
drug
cep
selamectin
mefloquin
hydrochlorid
consid
investig
treat
infect
due
amen
natur
model
could
play
import
role
develop
therapi
vaccin
high
homolog
isol
could
potenti
live
vaccin
candid
cultur
long
outbreak
isol
might
play
signific
role
combat
thu
model
part
reflect
import
sustain
coronaviru
surveil
wildlif
